WHO recommended the use of the Xpert MTB/RIF – an automated nucleic amplification assay for the simultaneous detection of TB and rifampicin resistance directly from sputum in under two hours. In line with these recommendations, Georgia piloted use of the technology in Tbilisi and initiated its roll-out countrywide in 2014. The initiative has been jointly supported by the Global Fund TB project and USAID TPP. The Global Fund TB project has purchased an additional nine GeneXpert machines which arrived into the country early 2015. The TPP supported installation of Xpert MTB/RIF Systems and initial training of laboratory technicians at all selected laboratories including in the penitentiary facilities.

From February 7, to March 11, 2015 9 Xpert MTB/RIF Systems were installed and 16 laboratory technicians were trained in 7 laboratories of NCDC (Gori, Akhaltsikhe, Telavi, Batumi, Ozurgeti, Poti, Zugdidi) and in 2 laboratories of Penitentiary system.